The effect of NAT2 slow acetylation was stronger for smokers of black tobacco, and GSTM1 may reduce the risk of bladder cancer through mechanisms that are not specific to the detoxification of polycyclic aromatic hydrocarbons (PAHs) in tobacco smoke16, 18. This evidence concerns the gene NAT2 and urinary bladder carcinoma.